Annual FCF
$100.45 M
+$148.11 M+310.77%
31 December 2023
Summary:
ANI Pharmaceuticals annual free cash flow is currently $100.45 million, with the most recent change of +$148.11 million (+310.77%) on 31 December 2023. During the last 3 years, it has risen by +$153.50 million (+289.33%). ANIP annual FCF is now at all-time high.ANIP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$7.03 M
-$5.93 M-45.77%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly free cash flow is currently $7.03 million, with the most recent change of -$5.93 million (-45.77%) on 30 September 2024. Over the past year, it has dropped by -$20.59 million (-74.54%). ANIP quarterly FCF is now -82.41% below its all-time high of $39.96 million, reached on 31 December 2023.ANIP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$73.64 M
-$20.59 M-21.85%
30 September 2024
Summary:
ANI Pharmaceuticals TTM free cash flow is currently $73.64 million, with the most recent change of -$20.59 million (-21.85%) on 30 September 2024. Over the past year, it has increased by +$20.70 million (+39.10%). ANIP TTM FCF is now -26.68% below its all-time high of $100.45 million, reached on 31 December 2023.ANIP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +310.8% | -74.5% | +39.1% |
| 3 y3 years | +289.3% | +217.5% | +572.4% |
| 5 y5 years | +78.8% | -64.6% | +80.2% |
ANIP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +289.3% | -82.4% | +133.3% | -26.7% | +220.0% |
| 5 y | 5 years | at high | +289.3% | -82.4% | +112.6% | -26.7% | +220.0% |
| alltime | all time | at high | +182.6% | -82.4% | +109.4% | -26.7% | +150.7% |
ANI Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.03 M(-45.8%) | $73.64 M(-21.8%) |
| June 2024 | - | $12.96 M(-5.3%) | $94.23 M(-0.9%) |
| Mar 2024 | - | $13.69 M(-65.7%) | $95.06 M(-5.4%) |
| Dec 2023 | $100.45 M(-310.8%) | $39.96 M(+44.7%) | $100.45 M(+89.7%) |
| Sept 2023 | - | $27.62 M(+100.1%) | $52.95 M(+176.6%) |
| June 2023 | - | $13.80 M(-27.6%) | $19.14 M(-356.3%) |
| Mar 2023 | - | $19.07 M(-352.9%) | -$7.47 M(-84.3%) |
| Dec 2022 | -$47.66 M(+134.6%) | -$7.54 M(+21.8%) | -$47.66 M(-9.5%) |
| Sept 2022 | - | -$6.19 M(-51.7%) | -$52.67 M(+0.4%) |
| June 2022 | - | -$12.80 M(-39.4%) | -$52.46 M(-14.5%) |
| Mar 2022 | - | -$21.12 M(+68.2%) | -$61.37 M(+202.1%) |
| Dec 2021 | -$20.32 M(-61.7%) | -$12.55 M(+109.7%) | -$20.32 M(+30.3%) |
| Sept 2021 | - | -$5.99 M(-72.4%) | -$15.59 M(-8.4%) |
| June 2021 | - | -$21.71 M(-208.9%) | -$17.03 M(-175.0%) |
| Mar 2021 | - | $19.93 M(-354.6%) | $22.71 M(-142.8%) |
| Dec 2020 | -$53.05 M(-393.4%) | -$7.83 M(+5.5%) | -$53.05 M(+26.9%) |
| Sept 2020 | - | -$7.42 M(-141.2%) | -$41.80 M(+188.0%) |
| June 2020 | - | $18.03 M(-132.3%) | -$14.51 M(-54.3%) |
| Mar 2020 | - | -$55.84 M(-1728.3%) | -$31.76 M(-275.6%) |
| Dec 2019 | $18.08 M(-67.8%) | $3.43 M(-82.7%) | $18.08 M(-55.8%) |
| Sept 2019 | - | $19.86 M(+2426.8%) | $40.88 M(+46.2%) |
| June 2019 | - | $786.00 K(-113.1%) | $27.96 M(-5.3%) |
| Mar 2019 | - | -$5.99 M(-122.9%) | $29.52 M(-47.4%) |
| Dec 2018 | $56.16 M(-181.9%) | $26.23 M(+277.5%) | $56.16 M(-1384.3%) |
| Sept 2018 | - | $6.95 M(+197.1%) | -$4.37 M(-233.2%) |
| June 2018 | - | $2.34 M(-88.7%) | $3.28 M(-342.0%) |
| Mar 2018 | - | $20.65 M(-160.2%) | -$1.36 M(-98.0%) |
| Dec 2017 | -$68.57 M(-43.6%) | -$34.31 M(-334.9%) | -$68.57 M(+190.9%) |
| Sept 2017 | - | $14.60 M(-734.1%) | -$23.57 M(-38.3%) |
| June 2017 | - | -$2.30 M(-95.1%) | -$38.18 M(-59.2%) |
| Mar 2017 | - | -$46.56 M(-535.5%) | -$93.57 M(-23.0%) |
| Dec 2016 | -$121.59 M(+688.6%) | $10.69 M(<-9900.0%) | -$121.59 M(-5.5%) |
| Sept 2016 | - | -$5000.00(-100.0%) | -$128.68 M(-11.4%) |
| June 2016 | - | -$57.69 M(-22.6%) | -$145.21 M(+67.9%) |
| Mar 2016 | - | -$74.58 M(-2173.5%) | -$86.51 M(+461.1%) |
| Dec 2015 | -$15.42 M(+12.4%) | $3.60 M(-121.8%) | -$15.42 M(+79.0%) |
| Sept 2015 | - | -$16.53 M(-1740.1%) | -$8.61 M(-17.6%) |
| June 2015 | - | $1.01 M(-128.9%) | -$10.45 M(+7.1%) |
| Mar 2015 | - | -$3.49 M(-133.6%) | -$9.76 M(-28.9%) |
| Dec 2014 | -$13.72 M(+141.8%) | $10.40 M(-156.6%) | -$13.72 M(-49.2%) |
| Sept 2014 | - | -$18.37 M(-1179.9%) | -$27.02 M(+162.0%) |
| June 2014 | - | $1.70 M(-122.8%) | -$10.31 M(+14.8%) |
| Mar 2014 | - | -$7.46 M(+157.6%) | -$8.99 M(+58.3%) |
| Dec 2013 | -$5.67 M(-78.1%) | -$2.89 M(+73.8%) | -$5.67 M(-5.9%) |
| Sept 2013 | - | -$1.67 M(-155.0%) | -$6.03 M(-50.6%) |
| June 2013 | - | $3.03 M(-173.1%) | -$12.21 M(-45.2%) |
| Mar 2013 | - | -$4.15 M(+27.7%) | -$22.30 M(-13.9%) |
| Dec 2012 | -$25.89 M | -$3.25 M(-58.6%) | -$25.89 M(-23.0%) |
| Sept 2012 | - | -$7.85 M(+11.2%) | -$33.65 M(-12.6%) |
| June 2012 | - | -$7.06 M(-8.9%) | -$38.48 M(-15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$7.74 M(-29.6%) | -$45.64 M(-6.1%) |
| Dec 2011 | -$48.59 M(+21.0%) | -$11.00 M(-13.3%) | -$48.59 M(-6.2%) |
| Sept 2011 | - | -$12.69 M(-10.7%) | -$51.83 M(+3.7%) |
| June 2011 | - | -$14.21 M(+32.9%) | -$50.00 M(+11.9%) |
| Mar 2011 | - | -$10.69 M(-24.9%) | -$44.69 M(+11.3%) |
| Dec 2010 | -$40.16 M(+116.0%) | -$14.24 M(+31.1%) | -$40.16 M(+25.2%) |
| Sept 2010 | - | -$10.86 M(+22.0%) | -$32.07 M(+28.6%) |
| June 2010 | - | -$8.90 M(+44.2%) | -$24.94 M(+23.8%) |
| Mar 2010 | - | -$6.17 M(+0.3%) | -$20.15 M(+8.4%) |
| Dec 2009 | -$18.60 M(+14.9%) | -$6.15 M(+64.9%) | -$18.60 M(+21.5%) |
| Sept 2009 | - | -$3.73 M(-9.2%) | -$15.30 M(-13.2%) |
| June 2009 | - | -$4.11 M(-11.0%) | -$17.63 M(-3.8%) |
| Mar 2009 | - | -$4.61 M(+61.5%) | -$18.32 M(+13.2%) |
| Dec 2008 | -$16.19 M(-2377.9%) | -$2.86 M(-52.8%) | -$16.19 M(+34.3%) |
| Sept 2008 | - | -$6.06 M(+26.2%) | -$12.06 M(+49.4%) |
| June 2008 | - | -$4.80 M(+93.9%) | -$8.07 M(+51.7%) |
| Mar 2008 | - | -$2.47 M(-294.1%) | -$5.32 M(-848.7%) |
| Dec 2007 | $710.60 K(-114.1%) | $1.27 M(-161.5%) | $710.50 K(+15.5%) |
| Sept 2007 | - | -$2.07 M(+1.3%) | $615.40 K(-52.9%) |
| June 2007 | - | -$2.05 M(-157.6%) | $1.31 M(+61.3%) |
| Mar 2007 | - | $3.56 M(+201.3%) | $809.70 K(-116.1%) |
| Dec 2006 | -$5.04 M(-39.8%) | $1.18 M(-185.4%) | -$5.04 M(-32.1%) |
| Sept 2006 | - | -$1.38 M(-45.7%) | -$7.41 M(-5.0%) |
| June 2006 | - | -$2.54 M(+11.0%) | -$7.80 M(-2.2%) |
| Mar 2006 | - | -$2.29 M(+91.2%) | -$7.98 M(-4.6%) |
| Dec 2005 | -$8.36 M(-20.7%) | -$1.20 M(-32.4%) | -$8.37 M(-21.8%) |
| Sept 2005 | - | -$1.77 M(-34.7%) | -$10.70 M(-8.3%) |
| June 2005 | - | -$2.72 M(+1.5%) | -$11.67 M(+2.7%) |
| Mar 2005 | - | -$2.68 M(-24.3%) | -$11.36 M(+7.7%) |
| Dec 2004 | -$10.55 M(+90.7%) | -$3.53 M(+29.0%) | -$10.55 M(+25.6%) |
| Sept 2004 | - | -$2.74 M(+13.7%) | -$8.40 M(+15.7%) |
| June 2004 | - | -$2.41 M(+29.3%) | -$7.26 M(+22.5%) |
| Mar 2004 | - | -$1.86 M(+34.4%) | -$5.92 M(+7.1%) |
| Dec 2003 | -$5.53 M(+38.2%) | -$1.39 M(-13.3%) | -$5.53 M(+23.9%) |
| Sept 2003 | - | -$1.60 M(+48.8%) | -$4.47 M(+17.6%) |
| June 2003 | - | -$1.07 M(-27.0%) | -$3.80 M(-8.2%) |
| Mar 2003 | - | -$1.47 M(+358.6%) | -$4.14 M(+3.3%) |
| Dec 2002 | -$4.00 M(+109.4%) | -$321.00 K(-65.5%) | -$4.00 M(-21.0%) |
| Sept 2002 | - | -$929.30 K(-34.2%) | -$5.07 M(+60.4%) |
| June 2002 | - | -$1.41 M(+5.6%) | -$3.16 M(+28.3%) |
| Mar 2002 | - | -$1.34 M(-3.4%) | -$2.46 M(+28.8%) |
| Dec 2001 | -$1.91 M(-40.2%) | -$1.38 M(-241.5%) | -$1.91 M(+75.1%) |
| Sept 2001 | - | $978.50 K(-236.6%) | -$1.09 M(-60.6%) |
| June 2001 | - | -$716.50 K(-9.1%) | -$2.77 M(-21.2%) |
| Mar 2001 | - | -$787.80 K(+39.4%) | -$3.51 M(+9.9%) |
| Dec 2000 | -$3.19 M(+78.2%) | -$565.20 K(-18.8%) | -$3.19 M(+21.5%) |
| Sept 2000 | - | -$696.20 K(-52.3%) | -$2.63 M(+36.0%) |
| June 2000 | - | -$1.46 M(+208.8%) | -$1.93 M(+308.8%) |
| Mar 2000 | - | -$472.50 K | -$472.50 K |
| Dec 1999 | -$1.79 M(-43.4%) | - | - |
| Dec 1998 | -$3.17 M | - | - |
FAQ
- What is ANI Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual FCF year-on-year change?
- What is ANI Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly FCF year-on-year change?
- What is ANI Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM FCF year-on-year change?
What is ANI Pharmaceuticals annual free cash flow?
The current annual FCF of ANIP is $100.45 M
What is the all time high annual FCF for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual free cash flow is $100.45 M
What is ANI Pharmaceuticals annual FCF year-on-year change?
Over the past year, ANIP annual free cash flow has changed by +$148.11 M (+310.77%)
What is ANI Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ANIP is $7.03 M
What is the all time high quarterly FCF for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly free cash flow is $39.96 M
What is ANI Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ANIP quarterly free cash flow has changed by -$20.59 M (-74.54%)
What is ANI Pharmaceuticals TTM free cash flow?
The current TTM FCF of ANIP is $73.64 M
What is the all time high TTM FCF for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM free cash flow is $100.45 M
What is ANI Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ANIP TTM free cash flow has changed by +$20.70 M (+39.10%)